Tong C, Wu Y, Zhang L, Yu Y
It is given as a once-weekly subcutaneous injection, with doses escalated gradually under medical supervision in clinical trials
Developed by the pharmaceutical company Eli Lilly, Zepbound offers a novel approach to weight management by combining the effects of two hormones: glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP)
Sterile solvent: You will need a diluent such as sterile water for injection, bacteriostatic water , or other buffer/saline solutions (e.g., 0.9% NaCl, acetic acid, etc)
applications, along with numerous foreign issued patents and pending applications